PM

Priyanka Mazumdar

Active Director Director DIN 10468198
DIN 10468198 First appointment Jan 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Priyanka Mazumdar

Data last updated:

Priyanka Mazumdar is a Director at Niramya Health And Cure Private Limited (since 2024). Niramya Health And Cure Private Limited reported revenue of ₹75,822 (FY 2025).

DIN 10468198
Primary Designation Director
First Appointment 17 Jan 2024
Oldest Company Age 2 yrs
Largest company Niramya Health And Cure Private Limited · ₹75,822 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jan 20242024₹75,822 (FY 2025)Active

Board colleagues of Priyanka Mazumdar

NameDINCompanyDesignation
Kapil Gupta10468197Niramya Health And Cure Private LimitedDirector

Directorship timeline

Open interactive timeline →
Niramya Health And Cure Private Limited
Premium access

Shareholding and investment profile for Priyanka Mazumdar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Mazumdar

Priyanka Mazumdar currently holds 1 directorship: Niramya Health And Cure Private Limited (Director, since 17 Jan 2024, revenue ₹75,822 (FY 2025)).

Priyanka Mazumdar was first appointed on 17 Jan 2024 as Director at Niramya Health And Cure Private Limited.

The current boards of Priyanka Mazumdar's companies include Kapil Gupta (Niramya Health And Cure Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available